Fundacion Seimc Gesida

Address
Calle De Agustin De Betancourt 13 Entreplanta

Sponsor Overview

assignment
3
sponsored trials
science
9
molecules
location_city
26
research centres
public
1
country
person_search
43
investigators

Specializations

HIV Treatment and Antiretroviral Therapy

Fundacion Seimc Gesida focuses on clinical research in HIV care, with interest in maintaining virological suppression and evaluating treatment options for adults living with the infection. Its studies examine regimen selection and treatment continuation in people with stable control of HIV.

  • Antiretroviral therapy
  • Virological suppression
  • Treatment switching

The sponsor’s work also includes comparisons of modern integrase inhibitor-based combinations used in long-term management of HIV.

Metabolic Liver Disease in HIV-Infected People

A second area of interest is metabolic liver disease associated with HIV infection, including liver health in individuals receiving ongoing antiretroviral treatment. The research addresses liver fibrosis and non-invasive assessment of hepatic disease burden.

  • Liver fibrosis
  • Metabolic dysfunction
  • Non-invasive liver evaluation

This reflects a clinical focus on liver-related complications that coexist with chronic HIV care.

Regimen Safety and Tolerability

The sponsor is active in studies evaluating the safety and tolerability of switching between established antiretroviral combinations. These trials address treatment suitability in people with good disease control and additional clinical considerations.

  • Switching therapy
  • Treatment tolerability
  • Clinical safety

Particular attention is given to maintaining stable HIV control while assessing regimen compatibility with patient needs.

Neuropsychiatric Vulnerabilities in HIV Care

Another relevant theme is the management of neuropsychiatric vulnerabilities in people living with HIV, especially when considering changes in treatment. The research landscape includes clinical interest in how antiretroviral choices relate to patient well-being beyond viral control.

  • Neuropsychiatric symptoms
  • Patient vulnerability
  • Therapy selection

This area links infectious disease management with attention to mental and neurological health considerations in long-term care.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 9 total (11% not shared with other sponsors)

This sponsor works with 9 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
35%
Return partnership rate
9 of 26 sites collaborated multiple times

This sponsor has worked with 26 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Virus Diseases3 trials
    182 other sponsors
  • 2.
    Digestive System Diseases1 trial
    280 other sponsors

Partnered Research Centres

26 centres
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment944
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Address
Paseo De La Castellana 261, 28046 Madrid
Learn morearrow_forward
location_city
assignment112
Hospital Alvaro Cunqueiro
Address
Estrada Clara Campoamor No 341, 36312 Vigo
Learn morearrow_forward
location_city
assignment1049
Hospital Clinic De Barcelona
Address
Calle Villarroel 170, 08036 Barcelona
Learn morearrow_forward
location_city
assignment579
Hospital Clinico San Carlos
Address
Calle Del Profesor Martin Lagos Sn, 28040 Madrid
Learn morearrow_forward
location_city
assignment114
Hospital Clinico Universitario De Valladolid
Address
Avenida Ramon Y Cajal 3, 47003 Valladolid
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Fundacion Seimc Gesida.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.